Breast Cancer News and Research

Latest Breast Cancer News and Research

Drive for expediency should not compromise care in breast cancer diagnosis, treatment

While timely care can reduce stress among breast cancer patients about their condition, the drive for expediency should not compromise other factors important to care, such as safety, effectiveness, efficiency, and equity, according to new research findings published in the April issue of the Journal of the American College of Surgeons.

4 May 2010

Fudged cancer patient waiting times reports, says AMAQ

The Australian Medical Association of Queensland (AMAQ) recently revealed that the state’s health authorities are keeping the truth about waiting time for cancer patients under wraps.

4 May 2010

Broccoli component sulforaphane targets and kills breast cancer stem cells

A compound derived from broccoli could help prevent or treat breast cancer by targeting cancer stem cells -- the small number of cells that fuel a tumor's growth -- according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

4 May 2010

NIH awards Hutchinson Center $10.24M for research of breast cancer disparities in Hispanic women

The National Institutes of Health has awarded $10.24 million to Fred Hutchinson Cancer Research Center to lead a five-year study that aims to understand and prevent breast cancer disparities in Hispanic women.

4 May 2010

NIH awards UIC $10M grant to study health disparities among underserved, minority women with breast cancer

A $9.6 million grant from the National Institutes of Health has been awarded to the University of Illinois at Chicago to study access to care and health disparities among underserved and minority women with breast cancer in Chicago.

4 May 2010

FDA issues advisory on prostate cancer drugs

Gonadotropin-Releasing Hormone (GnRH) agonists, a class of medications primarily used to treat men with prostate cancer, have been associated with a small increased risk for diabetes, heart attack, stroke, and sudden death in men treated with one of the medications, according to a preliminary and ongoing analysis of several studies by the U.S. Food and Drug Administration.

3 May 2010

Interim study results demonstrate anti-tumor activity of CytRx's INNO-206 in myeloma tumor cells

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced interim study results that showed its doxorubicin prodrug INNO-206 demonstrated statistically significant anti-tumor activity in human myeloma tumor cells growing in immune-deficient mice compared to a control group, while exhibiting significantly less toxicity than doxorubicin even though INNO-206 was administered at much higher doses.

3 May 2010

BioSante Pharmaceuticals reinitiates GVAX Prostate Cancer Vaccine development

BioSante Pharmaceuticals, Inc. today announced that development of its GVAX Prostate Cancer Vaccine (GVAX Prostate) for the treatment of prostate cancer has been reinitiated. Manufacturing of new GVAX Prostate is in process, regulatory steps to lift the GVAX Prostate clinical hold prior to trial initiation are being taken, and prostate cancer patients are expected to be treated in a Phase II human clinical trial beginning in the fourth quarter of 2010 at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.

3 May 2010

PEAK Surgical announces positive results from two PRECISE Clinical Studies for breast cancer diagnosis

PEAK Surgical, Inc. today announced positive results from two of its ongoing PRECISE Clinical Studies (Pulsed Plasma Radiofrequency to ReduCe Thermal Injury and Improve Surgical HEaling) demonstrating the clinical benefits of using the PEAK PlasmaBlade® tissue dissection device during lumpectomy for the diagnosis of breast cancer. The study findings were presented at the 11th Annual Meeting of the American Society of Breast Surgeons (ASBS) in poster sessions.

3 May 2010

BSGI improves breast cancer detection

A new study, presented at the American Society of Breast Surgeons Annual Meeting in Las Vegas, found that Breast-Specific Gamma Imaging (BSGI) is highly accurate in monitoring the response of breast cancers to neoadjuvant chemotherapy.

3 May 2010

New research suggests tumor-secreted exosomes inhibit immune response, enhance tumor metastasis

Current research suggests that tumor-secreted exosomes inhibit the immune response, enhancing tumor metastasis. The related report by Liu et al, "Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells," appears in the May 2010 issue of The American Journal of Pathology.

3 May 2010

Research roundup: Managing nursing home patients, streamlining medical billing, financial disclosures

Saving Billions Of Dollars--And Physicians' Time--By Streamlining Billing Practices - "The U.S. system of billing third parties for health care services is complex, expensive, and inefficient," write the authors, who analyzed Massachusetts General Physicians Organization staffing and cost data in fiscal year 2006.

3 May 2010

ZIOPHARM reports a net loss of $17.7 million in first quarter 2010

ZIOPHARM Oncology, Inc., a biopharmaceutical company that is seeking to develop and commercialize a diverse, risk sensitive portfolio of in-licensed cancer drugs addressing unmet medical needs, today reported its financial results for the three months ended March 31, 2010 and updated the Company's continued progress with its clinical programs.

3 May 2010

Obese women more likely to have breast cancer at later stage: Study

Obese women are more likely to have breast cancer detected at a later stage and to have lymph node metastases when diagnosed than women who are not obese, according to a study presented this week at the Annual Meeting of the American Society of Breast Surgeons.

3 May 2010

Smoking can increase risk of second cancer in breast cancer survivors

Women who survive early-stage breast cancer and smoke have an increased chance of developing a new second cancer in their other breast or elsewhere.

3 May 2010

McGill scientist discovers how one particular gene regulates epithelial cells

New research led by McGill Biochemist Dr. William Muller helps explain why breast-milk cells lose their structure, causing them to clump up in strange ways (photos available) and sometimes become cancer tumors. With the support of Chen Ling and Dongmei Zuo at McGill's Goodman Cancer Centre, Muller has discovered how one particular gene regulates epithelial cells - cells that normally form in sheets and are polarized to enable the transport of molecules in a single direction.

30 Apr 2010

Leading experts deliver breast cancer updates at unique public forum

While significant advances have been made in breast cancer care, evidence has shown that Ontarians diagnosed with breast cancer continue to face considerable challenges with their needs for information, support and care. To respond to these needs, the Canadian Breast Cancer Foundation - Ontario Region is working with leaders in research, clinical care and community support to deliver current breast cancer information and education at a free public forum presented by Scotiabank Group in Barrie called Breast Cancer Today: An Evening of Care and Community.

30 Apr 2010

Update on BioSante cancer vaccine portfolio to be presented at BIO International Convention

BioSante Pharmaceuticals, Inc. will present a BioSante cancer vaccine portfolio update at the BIO International Convention, which will take place May 3-6 in Chicago, Illinois.

30 Apr 2010

HHS Secretary to host web chat to discuss impact of newly passed health insurance reform law

HHS Secretary Sebelius, Jay Angoff, director of the Office of Consumer Information and Insurance Oversight, and Keysha Brooks Coley, the director of Federal Relations with the American Cancer Society, will host a web chat Friday, April 30 to discuss important insurance reforms in the new legislation and recent developments that have led to the ending of controversial practices like rescissions.

30 Apr 2010

Jumping elements in primates may have important consequences for studies of human genetic diseases

The density of transposable (jumping) elements between sex chromosomes in primates may have important consequences for the studies of human genetic diseases, say Penn State University researchers.

30 Apr 2010

Breast Cancer News and Research

Latest Breast Cancer News and Research

Drive for expediency should not compromise care in breast cancer diagnosis, treatment

Fudged cancer patient waiting times reports, says AMAQ

Broccoli component sulforaphane targets and kills breast cancer stem cells

NIH awards Hutchinson Center $10.24M for research of breast cancer disparities in Hispanic women

NIH awards UIC $10M grant to study health disparities among underserved, minority women with breast cancer

FDA issues advisory on prostate cancer drugs

Interim study results demonstrate anti-tumor activity of CytRx's INNO-206 in myeloma tumor cells

BioSante Pharmaceuticals reinitiates GVAX Prostate Cancer Vaccine development

PEAK Surgical announces positive results from two PRECISE Clinical Studies for breast cancer diagnosis

BSGI improves breast cancer detection

New research suggests tumor-secreted exosomes inhibit immune response, enhance tumor metastasis

Research roundup: Managing nursing home patients, streamlining medical billing, financial disclosures

ZIOPHARM reports a net loss of $17.7 million in first quarter 2010

Obese women more likely to have breast cancer at later stage: Study

Smoking can increase risk of second cancer in breast cancer survivors

McGill scientist discovers how one particular gene regulates epithelial cells

Leading experts deliver breast cancer updates at unique public forum

Update on BioSante cancer vaccine portfolio to be presented at BIO International Convention

HHS Secretary to host web chat to discuss impact of newly passed health insurance reform law

Jumping elements in primates may have important consequences for studies of human genetic diseases

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in